The Analysis of Serum Levels of NPY,SP and Associated Factors in Patients With Bipolar Depressive Disorders.

LIAO Jiwu,PAN Jiyang,LIU Yaping
2011-01-01
Abstract:Objective To explore the serum levels of neuropeptide Y(NPY) and substance P(SP) in patients with bipolar depressive disorders and associated factors.Methods Forty patients with bipolar depressive disorder and forty controls were recruited in the study.Hamilton Depression and Hamilton Anxiety Scales were used to assess the clinical symptoms.Serum NPY and SP concentrations were determined using enzyme-linked immunosorbent assay.Results Compared with controls,serum NPY was significantly lower [(5.09±1.77)ug/mL vs(8.70±2.18),ug/mL,P<0.01] whereas serum SP was significantly higher [(5.31±1.43)ug/mLvs(4.11±1.33)ug/mL,P<0.01] in patients.Serum NPY levels were not correlated with total duration of disorder,duration of a single attack,HAMA total score,HAMD total score or factor scores(P>0.05).In contrast,serum SP levels were positively correlated with the HAMD sleep disturbance factors(β=0.33,P=0.01).Conclusions Serum NPY and SP may play a role in the pathogenesis of bipolar depressive disorder.
What problem does this paper attempt to address?